Page 71 - Giessen News Today

 E-Mail IMAGE: In tests of the new lenses, the reference lens (left) shows color seams due to chromatic aberrations. The 3D printed achromat lenses (middle) reduced these drastically while images taken with... view more  Credit: Michael Schmid, University of Stuttgart WASHINGTON -- In a new study, researchers have shown that 3D printing can be used to make highly precise and complex miniature lenses with sizes of just a few microns. The microlenses can be used to correct color distortio...

It’s smarter and safer for institutional investors to diversify their portfolios by industry, rather than implementing country-based strategies.  Industry-based asset allocation strategies offer better diversification and yield higher risk-adjusted results than country-based strategies, according to a study by Wolfgang Bessler of the University of Hamburg, Georgi Taushanov of Justus-Liebig-University Giessen, and Dominik Wolff of the Institute for Quantitative Capital Market Research at Deka...

Flags of Georgia and Moldova. Author: Borka Kiss / Shutterstock A political crisis is only over when the underlying issues causing it have been resolved. Does this logic apply to recent events in Georgia and Moldova? Currently, there is no straightforward answer. Certainly, the latest developments in Georgia and Moldova allow for some cautious optimism. There have been huge improvements in both countries regarding their recent crises. However, only one of these nations seems to be truly approac...

Share Plant-based seafood analog products continue to gain in popularity in Europe. To meet that demand, suppliers have been launching new plant-based products, while companies traditionally aligned with the seafood industry have been investing in plant-based firms. Agriculture giant Cargill is investing in Bflike, a start-up created by BOX NV. Bflike has patent-pending vegan fat and blood platforms, and it plans to license its proprietary technology and premix ingredient solutions to food ...

Last modified on Mon 26 Apr 2021 14.43 EDT Christa Ludwig, who has died aged 93, was one of the outstanding singers of her generation, acclaimed alike in lieder and opera, where she was highly regarded for her matchless interpretations of an impressively wide range of roles. Making her debut at the Vienna State Opera in 1955, she remained with the company for more than 30 years, giving 769 performances of 42 roles. There she won the undying affection and admiration of the public, the whipped-cr...

Sunday, April 25, 2021 Christa Ludwig acknowledges her Gramophone Lifetime Achievement Award in 2016 Christa Ludwig has died at the age of 93, one of the great singers of the post-war years, and an artist beloved of conductors as different as Otto Klemperer, Karl Böhm, Herbert von Karajan, Leonard Bernstein, Sir Georg Solti, James Levine and Seiji Ozawa. James Jolly recalls a glorious career. The only time London audiences heard Christa Ludwig sing in English was in concert per...

Christa Ludwig in 1978 Credit:  Avalon Christa Ludwig, the mezzo-soprano, who has died aged 93, started out singing for cigarettes in post-war Berlin and ended up one of the world’s leading exponents of opera and leider. During one of the longest and most distinguished careers on the operatic stage, Christa Ludwig made her debut in Frankfurt in 1946 as Prince Orlovsky in Die Fledermaus and gave her farewell performance in Vienna in 1994, as Klytemnestra in Strauss’s Elektra. Her repertoir...

Elixir Medical Corporation: Elixir Medical Expands BIOADAPTOR Randomized Controlled Trial of DynamX Coronary Bioadaptor System Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that the BIOADAPTOR randomized controlled trial (RCT) is expanding to centers in Belgium and Germany. The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System, the first drug-eluting coronary artery implant that adapts to vessel physiology. The BIOADAPTOR RC...

First Patient Treated in Elixer Dynamx Coronary Bioadaptor Stent Technology International trial compares Bioadaptor coronary stent designed to adapt to vessel physiology with stanard DES The Elixer Dynamx Coronary Bioadaptor Stent technology uses a bioresorbable polymer that dissolves after three months and disconnected joints between numerous stent segments, allowing it to articulate and shape to the vessel and its movement. April, 14, 2021 – Elixir Medical recently announced the first pati...

Insect protein company Ÿnsect acquires Protifarm for ‘strategic boost’ in human nutrition French insect protein pioneer Ÿnsect has acquired Dutch mealworm specialist Protifarm in a move that the company says will give it a ‘strategic boost’ in the human nutrition market. Protifarm is ‘the global leader in mealworm ingredients for human health applications’, according to Ÿnsect, which unveiled the deal yesterday. Ÿnsect currently specializes in insect ...